Ironwood Pharmaceuticals (IRWD) News Today $7.04 +0.25 (+3.68%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 25 at 8:44 PM | stockhouse.comIronwood Pharmaceuticals to Host Second Quarter 2024 Investor Update CallJuly 25 at 12:26 PM | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 7.7%Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 7.7%July 25 at 5:56 AM | marketbeat.comState Board of Administration of Florida Retirement System Has $1.70 Million Stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)State Board of Administration of Florida Retirement System grew its position in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 339.4% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutionalJuly 23 at 10:47 AM | marketbeat.comEdgestream Partners L.P. Invests $2.58 Million in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Edgestream Partners L.P. purchased a new stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 296,287 shares of the biotechnology company's stock, valuedJuly 22, 2024 | marketbeat.comRussell Investments Group Ltd. Grows Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Russell Investments Group Ltd. raised its position in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 244.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 777,847 shares of the biJuly 21, 2024 | marketbeat.comJupiter Asset Management Ltd. Decreases Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Jupiter Asset Management Ltd. cut its holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 34.8% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 1,479,964 shares of the biotechnology company's stock after selling 790,078 shares during thJuly 19, 2024 | msn.comImplied Volatility Surging for Ironwood Pharmaceuticals (IRWD) Stock OptionsJuly 19, 2024 | marketbeat.comFirst Eagle Investment Management LLC Grows Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)First Eagle Investment Management LLC boosted its stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 10.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,002,225 sharJuly 18, 2024 | marketbeat.comFoundry Partners LLC Acquires New Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Foundry Partners LLC bought a new position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The fund bought 240,573 shares of the biotechnology company's stock, valued at approximately $2,095,000July 17, 2024 | marketbeat.comShort Interest in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Drops By 10.6%Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) was the target of a large drop in short interest in the month of June. As of June 30th, there was short interest totalling 18,070,000 shares, a drop of 10.6% from the June 15th total of 20,220,000 shares. Based on an average daily volume of 2,610,000 shares, the days-to-cover ratio is presently 6.9 days. Currently, 11.7% of the company's stock are short sold.July 17, 2024 | americanbankingnews.comIronwood Pharmaceuticals (NASDAQ:IRWD) Upgraded by StockNews.com to "Buy"July 16, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Upgraded at StockNews.comStockNews.com upgraded shares of Ironwood Pharmaceuticals from a "hold" rating to a "buy" rating in a research note on Tuesday.July 12, 2024 | marketbeat.comLSV Asset Management Sells 631,100 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)LSV Asset Management lowered its stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 9.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,151,001July 12, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap Up to $6.46Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap Up to $6.46July 11, 2024 | marketbeat.comGSA Capital Partners LLP Makes New $1.53 Million Investment in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)GSA Capital Partners LLP bought a new position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 176,172 shares of the biotechnology company's stock, valued at apprJuly 8, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Cut to "Hold" at StockNews.comStockNews.com downgraded Ironwood Pharmaceuticals from a "buy" rating to a "hold" rating in a research report on Monday.July 5, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Shares Up 5.2%Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 5.2%July 4, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Stock Holdings Boosted by Vanguard Group Inc.Vanguard Group Inc. increased its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 7.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 16,033,545 shares of the biotechnology comJuly 3, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Short Interest Down 10.8% in JuneIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) was the target of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 20,220,000 shares, a decrease of 10.8% from the May 31st total of 22,660,000 shares. Approximately 13.1% of the shares of the company are short sold. Based on an average daily volume of 2,760,000 shares, the short-interest ratio is currently 7.3 days.July 1, 2024 | marketbeat.comFY2025 Earnings Forecast for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Issued By Zacks ResearchIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Stock analysts at Zacks Research increased their FY2025 earnings per share (EPS) estimates for shares of Ironwood Pharmaceuticals in a research report issued to clients and investors on Wednesday, June 26th. Zacks Research analyst R. DeJune 29, 2024 | marketbeat.comHodges Capital Management Inc. Takes $7.52 Million Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Hodges Capital Management Inc. purchased a new stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 863,500 shares of the bioteJune 21, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Trading 3.6% Higher Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Up 3.6%June 20, 2024 | seekingalpha.comIronwood Pharmaceuticals: Q3 Of 2024 Data Readout For PBCJune 20, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Reaches New 52-Week Low at $5.47Ironwood Pharmaceuticals (NASDAQ:IRWD) Hits New 12-Month Low at $5.47June 18, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Rating Increased to Buy at StockNews.comStockNews.com raised Ironwood Pharmaceuticals from a "hold" rating to a "buy" rating in a research report on Tuesday.June 16, 2024 | marketbeat.comEventide Asset Management LLC Makes New $8.47 Million Investment in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Eventide Asset Management LLC acquired a new stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 740,554 shares of the bioteJune 15, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Consensus Rating of "Buy" from BrokeragesShares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) have earned an average recommendation of "Buy" from the five brokerages that are currently covering the company, Marketbeat reports. Five investment analysts have rated the stock with a buy recommendation. The average 1 yearJune 14, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Hits New 52-Week Low at $5.71Ironwood Pharmaceuticals (NASDAQ:IRWD) Hits New 52-Week Low at $5.71June 13, 2024 | insidertrades.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Director Sells $143,198.14 in StockJune 11, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 4.6% on Insider SellingIronwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 4.6% on Insider SellingJune 11, 2024 | insidertrades.comInsider Selling: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Director Sells 44,426 Shares of StockJune 10, 2024 | marketbeat.com13D Management LLC Has $4.21 Million Stock Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)13D Management LLC raised its holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 971.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 367,649 shares of the biotechnology companJune 8, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Quantedge Capital Pte LtdQuantedge Capital Pte Ltd trimmed its position in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 90.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 17,400 shares of the biotechnology cJune 7, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 3.3%Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Up 3.3%June 6, 2024 | marketbeat.comRafferty Asset Management LLC Sells 172,282 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Rafferty Asset Management LLC decreased its stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 19.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 701,770 shares of the bioteJune 5, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 2.8% Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 2.8%June 5, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Bought by Armistice Capital LLCArmistice Capital LLC grew its holdings in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 64.9% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 5,700,000 shares of the biotechnology company's stock after acquiring an additional 2,244,June 1, 2024 | marketbeat.comShort Interest in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Rises By 12.0%Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) was the target of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 22,480,000 shares, a growth of 12.0% from the April 30th total of 20,080,000 shares. Based on an average daily volume of 4,300,000 shares, the days-to-cover ratio is currently 5.2 days. Approximately 14.5% of the shares of the company are sold short.June 1, 2024 | marketbeat.comDimensional Fund Advisors LP Sells 2,435,165 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Dimensional Fund Advisors LP lessened its holdings in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 44.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,081,81May 31, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 5.1%Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 5.1%May 30, 2024 | businesswire.comIronwood Pharmaceuticals to Participate in the Jefferies Global Healthcare ConferenceMay 29, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Hits New 12-Month Low at $5.76Ironwood Pharmaceuticals (NASDAQ:IRWD) Hits New 1-Year Low at $5.76May 27, 2024 | marketbeat.comQ1 2025 Earnings Estimate for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Issued By Zacks ResearchIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Research analysts at Zacks Research reduced their Q1 2025 earnings per share estimates for Ironwood Pharmaceuticals in a report issued on Friday, May 24th. Zacks Research analyst R. Department now expects that the biotechnology companyMay 24, 2024 | marketbeat.comZacks Research Analysts Lower Earnings Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Equities researchers at Zacks Research cut their FY2024 earnings estimates for shares of Ironwood Pharmaceuticals in a research report issued on Wednesday, May 22nd. Zacks Research analyst R. Department now expects that the biotechnologMay 23, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Hits New 52-Week Low at $6.20Ironwood Pharmaceuticals (NASDAQ:IRWD) Reaches New 12-Month Low at $6.20May 23, 2024 | marketbeat.comAnalysts Set Expectations for Ironwood Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:IRWD)Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Investment analysts at Zacks Research reduced their Q2 2024 earnings estimates for Ironwood Pharmaceuticals in a research report issued to clients and investors on Wednesday, May 22nd. Zacks Research analyst R. Department now expects thMay 22, 2024 | markets.businessinsider.comIronwood Pharma’s Apraglutide Poised for Blockbuster Status with Strong Phase 3 Results: A Buy RatingMay 21, 2024 | markets.businessinsider.comIronwood Pharmaceuticals’ Growth Potential Bolstered by Promising LINZESS and Apraglutide Clinical DataMay 21, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Trading 3.3% Higher Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Up 3.3%May 21, 2024 | finance.yahoo.comIronwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF) Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address We’re in a code red crisis and 99% of Americans are clueless (Ad)Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! And how YOU can prepare for the next 2024 BOOM here! IRWD Media Mentions By Week IRWD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRWD News Sentiment▼0.910.62▲Average Medical News Sentiment IRWD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRWD Articles This Week▼84▲IRWD Articles Average Week Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IGM Biosciences News Cryoport News Kura Oncology News Zentalis Pharmaceuticals News Bausch Health Companies News Alkermes News Amicus Therapeutics News Geron News Celldex Therapeutics News Myriad Genetics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IRWD) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ironwood Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
